NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-128 Cr | ₹-205 Cr | ₹-186 Cr | ₹-119 Cr | ₹11 Cr |
What is the latest Cash Flow from Financing Activities ratio of NECTAR LIFESCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-128 Cr |
| Mar2024 | ₹-205 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹-119 Cr |
| Mar2021 | ₹11 Cr |
How is Cash Flow from Financing Activities of NECTAR LIFESCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-128 Cr | Negative | |
| Mar2024 | ₹-205 Cr | Negative | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹-119 Cr | Negative | |
| Mar2021 | ₹11 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹254.9 Cr | -2.7% | -5.5% | -59.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -2.7% |
-5.5% |
-59.8% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses